FI111016B - Menetelmä seuloa aineita, jotka moduloivat interleukiini-5-reseptorista riippuvaa signaalin välitysreittiä soluissa - Google Patents

Menetelmä seuloa aineita, jotka moduloivat interleukiini-5-reseptorista riippuvaa signaalin välitysreittiä soluissa Download PDF

Info

Publication number
FI111016B
FI111016B FI955700A FI955700A FI111016B FI 111016 B FI111016 B FI 111016B FI 955700 A FI955700 A FI 955700A FI 955700 A FI955700 A FI 955700A FI 111016 B FI111016 B FI 111016B
Authority
FI
Finland
Prior art keywords
receptor
cells
interleukin
substance
subunit
Prior art date
Application number
FI955700A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI955700A (fi
FI955700A0 (fi
Inventor
Armin Peter Czernilofsky
Ulrike Weyer-Czernilofsky
Ian G Young
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of FI955700A publication Critical patent/FI955700A/fi
Publication of FI955700A0 publication Critical patent/FI955700A0/fi
Application granted granted Critical
Publication of FI111016B publication Critical patent/FI111016B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI955700A 1993-05-27 1995-11-27 Menetelmä seuloa aineita, jotka moduloivat interleukiini-5-reseptorista riippuvaa signaalin välitysreittiä soluissa FI111016B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4317577 1993-05-27
DE4317577A DE4317577A1 (de) 1993-05-27 1993-05-27 Verfahren zum Screenen von Substanzen mit modulierender Wirkung auf einen Interleukin-5-Rezeptor-abhängigen zellulären Signalübertragungsweg
EP9401735 1994-05-27
PCT/EP1994/001735 WO1994028170A1 (de) 1993-05-27 1994-05-27 Verfahren zum screenen von substanzen mit modulierender wirkung auf einen interleukin-5-rezeptor-abhängigen zellulären signalübertragungsweg

Publications (3)

Publication Number Publication Date
FI955700A FI955700A (fi) 1995-11-27
FI955700A0 FI955700A0 (fi) 1995-11-27
FI111016B true FI111016B (fi) 2003-05-15

Family

ID=6488996

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955700A FI111016B (fi) 1993-05-27 1995-11-27 Menetelmä seuloa aineita, jotka moduloivat interleukiini-5-reseptorista riippuvaa signaalin välitysreittiä soluissa

Country Status (17)

Country Link
US (1) US5922549A (ru)
EP (1) EP0701628B1 (ru)
JP (1) JPH08510643A (ru)
KR (1) KR100318188B1 (ru)
CN (1) CN1125467A (ru)
AT (1) ATE162555T1 (ru)
AU (1) AU691816B2 (ru)
CA (1) CA2163549A1 (ru)
DE (2) DE4317577A1 (ru)
DK (1) DK0701628T3 (ru)
ES (1) ES2113109T3 (ru)
FI (1) FI111016B (ru)
HU (1) HU220345B (ru)
NO (1) NO316027B1 (ru)
NZ (1) NZ291131A (ru)
RU (1) RU2139936C1 (ru)
WO (1) WO1994028170A1 (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405350D0 (en) * 1994-03-18 1994-05-04 Sandoz Ltd Organic compounds
US5668110A (en) * 1995-06-07 1997-09-16 Affymax Technologies N.V. Peptides and compounds that bind to the IL-5 receptor
US5677280A (en) * 1995-06-07 1997-10-14 Glaxo Group Limited Peptides and compounds that bind to the IL-5 receptor
US5683983A (en) * 1995-06-07 1997-11-04 Glaxo Group Limited Peptides and compounds that bind to the IL-5 receptor
US5654276A (en) * 1995-06-07 1997-08-05 Affymax Technologies N.V. Peptides and compounds that bind to the IL-5 receptor
US7109299B1 (en) 1999-12-16 2006-09-19 Affymax, Inc. Peptides and compounds that bind to the IL-5 receptor
WO2002028168A1 (en) * 2000-10-03 2002-04-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education High efficiency regulatable gene expression system
US20040170614A1 (en) * 2002-10-30 2004-09-02 Gail Bishop Somatic cell gene targeting vectors and methods of use thereof
US20040209246A1 (en) * 2003-04-15 2004-10-21 Agouron Pharmaceuticals, Inc. Dual reporter/dye reduction methodology for evaluating antiviral and cytotoxicity of hepatitis C virus inhibitors
US20050112551A1 (en) * 2003-11-24 2005-05-26 Agouron Pharmaceuticals, Inc. Dual assay for evaluating activity and cytotoxicity of compounds in the same population of cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071773A (en) * 1986-10-24 1991-12-10 The Salk Institute For Biological Studies Hormone receptor-related bioassays
US5401629A (en) * 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
US5453491A (en) * 1990-09-11 1995-09-26 Kiyoshi Takatsu Murine interleukin-5 receptor
WO1992013063A1 (en) * 1991-01-18 1992-08-06 Oncogene Science, Inc. Methods of transcriptionally modulating expression of growth factor genes and growth factor receptor genes
AU655850B2 (en) * 1991-10-01 1995-01-12 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The A method of identifying ligands and antagonists of ligands

Also Published As

Publication number Publication date
NO954781L (no) 1996-01-23
CN1125467A (zh) 1996-06-26
EP0701628A1 (de) 1996-03-20
KR100318188B1 (ko) 2002-06-20
CA2163549A1 (en) 1994-12-08
NO954781D0 (no) 1995-11-24
AU691816B2 (en) 1998-05-28
KR960702532A (ko) 1996-04-27
WO1994028170A1 (de) 1994-12-08
HU220345B (hu) 2001-12-28
US5922549A (en) 1999-07-13
FI955700A (fi) 1995-11-27
NZ291131A (en) 1996-10-28
DE59405120D1 (de) 1998-02-26
NO316027B1 (no) 2003-12-01
ES2113109T3 (es) 1998-04-16
HUT73742A (en) 1996-09-30
EP0701628B1 (de) 1998-01-21
HU9503363D0 (en) 1996-01-29
DE4317577A1 (de) 1994-12-01
RU2139936C1 (ru) 1999-10-20
JPH08510643A (ja) 1996-11-12
FI955700A0 (fi) 1995-11-27
ATE162555T1 (de) 1998-02-15
AU6997794A (en) 1994-12-20
DK0701628T3 (da) 1998-09-21

Similar Documents

Publication Publication Date Title
Chaturvedi et al. Abrogation of interleukin-3 dependence of myeloid cells by the v-src oncogene requires SH2 and SH3 domains which specify activation of STATs
Ernst et al. The carboxyl-terminal domains of gp130-related cytokine receptors are necessary for suppressing embryonic stem cell differentiation: involvement of STAT3
Fujio et al. Signals through gp130 upregulate bcl-x gene expression via STAT1-binding cis-element in cardiac myocytes.
Wang et al. The antiapoptotic gene mcl-1 is up-regulated by the phosphatidylinositol 3-kinase/Akt signaling pathway through a transcription factor complex containing CREB
Gutman et al. The collagenase gene promoter contains a TPA and oncogene‐responsive unit encompassing the PEA3 and AP‐1 binding sites.
Van Lint et al. Transcription factor binding sites downstream of the human immunodeficiency virus type 1 transcription start site are important for virus infectivity
Cleveland et al. Tyrosine kinase oncogenes abrogate interleukin-3 dependence of murine myeloid cells through signaling pathways involving c-myc: conditional regulation of c-myc transcription by temperature-sensitive v-abl
Lugo et al. Tyrosine kinase activity and transformation potency of bcr-abl oncogene products
Matsui et al. Induction of interleukin (IL)-6 by hypoxia is mediated by nuclear factor (NF)-κB and NF-IL6 in cardiac myocytes
EP0483249B1 (en) Method of transcriptionally modulating gene expression and of discovering chemicals capable of functioning as gene expression modulators
Paul et al. Regulation of expression of the rat SOCS‐3 gene in hepatocytes by growth hormone, interleukin‐6 and glucocorticoids: mRNA analysis and promoter characterization
Kadri et al. Phosphatidylinositol 3-kinase/Akt induced by erythropoietin renders the erythroid differentiation factor GATA-1 competent for TIMP-1 gene transactivation
FI111016B (fi) Menetelmä seuloa aineita, jotka moduloivat interleukiini-5-reseptorista riippuvaa signaalin välitysreittiä soluissa
Hossain et al. G-protein γ subunit GNG11 strongly regulates cellular senescence
Marden et al. Role of activator protein-1 in the down-regulation of the human CYP2J2 gene in hypoxia
Kim et al. Thyrotropin-mediated repression of class II trans-activator expression in thyroid cells: involvement of STAT3 and suppressor of cytokine signaling
Sterneck et al. Structure of the chicken myelomonocytic growth factor gene and specific activation of its promoter in avian myelomonocytic cells by protein kinases
Mariner et al. IFN regulatory factor 4 participates in the human T cell lymphotropic virus type I-mediated activation of the IL-15 receptor α promoter
McCubrey et al. Effects of deregulated Raf and MEK1 expression on the cytokine-dependency of hematopoietic cells
Novak et al. In vitro transfection of fresh thymocytes and T cells shows subset-specific expression of viral promoters
Zastawny et al. Structural and functional analysis of 5′ flanking and intron 1 sequences of the hamster P-glycoprotein pgp1 and pgp2 genes
Chu et al. Interferon-γ regulates ClC-2 chloride channel in lung epithelial cells
Prassolov et al. Functional identification of secondary mutations inducing autonomous growth in synergy with a truncated interleukin-3 receptor: implications for multi-step oncogenesis
Ye et al. Transcriptional regulation of the mouse interleukin-2 receptor β chain gene by Ets and Egr-1
US20080096228A1 (en) Compositions And Methods Relating To Mammalian Internal Ribosome Entry Sites

Legal Events

Date Code Title Description
MA Patent expired